EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Protein S‑palmitoylation in T cell‑mediated antitumor immunity: Context‑dependent mechanisms and therapeutic opportunities (Review)

Shiting Wang, Rui Xu, Sikan Jin, Ting Yu, Ming Qin, Lin Xu, Xianyao Wang

International Journal of Molecular Medicine · 04.11.2026 · 58 (6) · 1-24

DOI: 10.3892/ijmm.2026.6038 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, online erschienen am 04.11.2026. Verfasst von Shiting Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China. Hauptthemen laut MEDLINE: T-Lymphocytes, Neoplasms, Lipoylation. Die Arbeit nennt 226 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

S‑palmitoylation is a critical post‑translational regulator of protein function; however, its role in T cell‑mediated antitumor immunity remains unclear. The present review summarizes emerging evidence that redefines T cell biology and its implications for antitumor immunity. The regulatory functions of S‑palmitoylation in T cell receptor signaling, activation, proliferation, differentiation, exhaustion and apoptosis are first outlined, highlighting the distinct roles of the zinc finger Asp‑His‑His‑Cystype family of palmitoyl acyltransferases and depalmitoylating enzymes in modulating the membrane localization, stability and signal transduction of key T cell signaling regulators. How S‑palmitoylation of immune checkpoints, such as programmed death‑ligand 1, and the components of antigen presentation shape the tumor immune microenvironment were further examined. Additionally, the recent advances in therapeutic strategies targeting S‑palmitoylation, including small‑molecule inhibitors, peptide‑based interventions and nanoparticle delivery systems, were highlighted, and their potential to enhance T cell antitumor immunity, particularly in combination with immune checkpoint blockade, was discussed. Finally, the current challenges, including the suboptimal selectivity of pharmacological agents, technical limitations of existing delivery systems and the intrinsic heterogeneity and immunosuppressive nature of the tumor microenvironment were discussed, and future directions for advancing S‑palmitoylation‑targeted immunotherapies were proposed. Collectively, the present review highlights S‑palmitoylation as a promising regulatory axis for antitumor immunity and provides a foundation for the future development of targeted immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-LymphocytesNeoplasmsLipoylationHumansAnimalsTumor MicroenvironmentSignal TransductionImmunotherapy

Stichwörter der Autor:innen

S‑palmitoylationT cellantitumor immunityimmune checkpointtargeted therapy

Autor:innen und Institutionen

  • Department of Immunology, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.
  • Key Laboratory of Cancer Prevention and Treatment of Guizhou Province, Zunyi Medical University, Zunyi, Guizhou 563000, P.R. China.

Zitieren

APA

Wang, S., Xu, R., Jin, S., Yu, T., Qin, M., Xu, L., & Wang, X. (2026). Protein S‑palmitoylation in T cell‑mediated antitumor immunity: Context‑dependent mechanisms and therapeutic opportunities (Review). International Journal of Molecular Medicine, 58(6), 1-24. https://doi.org/10.3892/ijmm.2026.6038

Vancouver

Wang S, Xu R, Jin S, Yu T, Qin M, Xu L, et al. Protein S‑palmitoylation in T cell‑mediated antitumor immunity: Context‑dependent mechanisms and therapeutic opportunities (Review). International Journal of Molecular Medicine. 2026;58(6):1-24. doi:10.3892/ijmm.2026.6038

BibTeX
@article{Wang2026,
  author = {Wang, Shiting and Xu, Rui and Jin, Sikan and Yu, Ting and Qin, Ming and Xu, Lin and Wang, Xianyao},
  title = {Protein S‑palmitoylation in T cell‑mediated antitumor immunity: Context‑dependent mechanisms and therapeutic opportunities (Review)},
  journal = {International Journal of Molecular Medicine},
  year = {2026},
  volume = {58},
  number = {6},
  pages = {1--24},
  doi = {10.3892/ijmm.2026.6038}
}
Kostenlos starten →